CVD Risk Estimator Plus Estimate 10‑ and 30‑year risks for total CVD, ASCVD, and heart failure, using the combined strength of the new AHA PREVENT™ equations, as well as the previous Pooled Cohort ...

It is a tremendous honor to serve as Chair of ACC's Women in Cardiology (WIC) Member Section Leadership Council. I am deeply grateful to the visionary leaders who have built this extraordinary ...

As part of its broader strategy to expand specialty participation in value-based care, the Centers for Medicare and Medicaid Services (CMS) has finalized a mandatory five-year Ambulatory Specialty ...

Helping to shepherd the College further into the AI era with the creation of an AI implementation Task Force and the beginning of a relationship with Open Evidence. Advocacy! The College showed ...

According to the ACC/American Heart Association (AHA) guideline, all adults should undergo cholesterol screening to help assess long-term cardiovascular risk. 5,6 Serum LDL-C levels <100 mg/dL are ...

The PCSK9 inhibitor evolocumab reduced the risk of a first major cardiovascular event in patients with diabetes without known significant atherosclerosis, according to a prespecified subgroup analysis ...

Lowering LDL-C to <55 mg/dL in patients with atherosclerotic cardiovascular disease (ASCVD) reduced the rate of major cardiovascular events by one-third, according to the Ez-PAVE trial presented ...

When compared with angiography-guided PCI, IVUS-guided PCI was found to be not superior in patients with complex coronary arteries according to results from the IVUS-CHIP trial or in patients with ...

In the first head-to-head comparison of two embolic protection devices used during TAVR, the investigational Emboliner protection catheter performed comparably to the U.S. Food and Drug Administration ...

Compared with immediate PCI alone, the combination of mechanical left ventricular (LV) unloading using a transvalvular micro-axial flow pump (TV-mAFP) plus delayed PCI did not reduce infarct size in ...

In patients with acute, intermediate-risk pulmonary embolism (PE), ultrasound-facilitated, catheter-directed fibrinolysis plus anticoagulation led to a lower risk of PE-related death, cardiopulmonary ...

Older patients with coronary artery disease (CAD) for whom PCI was deferred until after TAVI had similar outcomes as those for whom it was not deferred, according to findings from the PRO-TAVI study ...